These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 2-Phenylindoles. Relationship between structure, estrogen receptor affinity, and mammary tumor inhibiting activity in the rat. von Angerer E; Prekajac J; Strohmeier J J Med Chem; 1984 Nov; 27(11):1439-47. PubMed ID: 6492074 [TBL] [Abstract][Full Text] [Related]
3. 2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity. von Angerer E; Strohmeier J J Med Chem; 1987 Jan; 30(1):131-6. PubMed ID: 3806590 [TBL] [Abstract][Full Text] [Related]
4. 3-Alkyl-2-phenylbenzo[b]thiophenes: nonsteroidal estrogen antagonists with mammary tumor inhibiting activity. von Angerer E; Erber S J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):557-62. PubMed ID: 1562527 [TBL] [Abstract][Full Text] [Related]
5. 6-Alkyl-12-formylindolo[2,1-a]isoquinolines. Syntheses, estrogen receptor binding affinities, and stereospecific cytostatic activity. Polossek T; Ambros R; von Angerer S; Brandl G; Mannschreck A; von Angerer E J Med Chem; 1992 Sep; 35(19):3537-47. PubMed ID: 1404234 [TBL] [Abstract][Full Text] [Related]
6. Platinum complexes with a selective action on estrogen receptor-positive mammary tumors. von Angerer E; Birnböck H; Knebel N Anticancer Drug Des; 1989 Jun; 4(1):21-35. PubMed ID: 2757751 [TBL] [Abstract][Full Text] [Related]
7. Influence of alkyl-chain fluorination on the action of mammary tumor inhibiting 2,3-bis(hydroxyphenyl)butanes and 2,3-bis(hydroxyphenyl)but-2-enes. Hartmann RW; Heindl A; Schneider MR; Schönenberger H J Med Chem; 1986 Mar; 29(3):322-8. PubMed ID: 3005573 [TBL] [Abstract][Full Text] [Related]
8. 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells. Erber S; Ringshandl R; von Angerer E Anticancer Drug Des; 1991 Nov; 6(5):417-26. PubMed ID: 1764164 [TBL] [Abstract][Full Text] [Related]
9. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 3. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of 2,2'-disubstituted butestrols and 6,6'-disubstituted metabutestrols. Hartmann RW; Heindl A; Schwarz W; Schönenberger H J Med Chem; 1984 Jul; 27(7):819-24. PubMed ID: 6330356 [TBL] [Abstract][Full Text] [Related]
10. 2-Phenylindole-linked [2-(aminoalkyl)pyridine]dichloroplatinum(II): complexes with a selective action on estrogen receptor positive mammary tumors. Knebel NG; von Angerer E J Med Chem; 1991 Jul; 34(7):2145-52. PubMed ID: 2066987 [TBL] [Abstract][Full Text] [Related]
11. Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanes. Hartmann RW; Schwarz W; Heindl A; Schönenberger H J Med Chem; 1985 Sep; 28(9):1295-301. PubMed ID: 2993619 [TBL] [Abstract][Full Text] [Related]
12. 2-Phenylindoles with sulfur containing side chains. Estrogen receptor affinity, antiestrogenic potency, and antitumor activity. Biberger C; von Angerer E J Steroid Biochem Mol Biol; 1996 Apr; 58(1):31-43. PubMed ID: 8809184 [TBL] [Abstract][Full Text] [Related]
13. Dibenzo[a,f]quinolizines: syntheses and cytostatic activity in estrogen-sensitive tumor cells. von Angerer S; Seidl E; Mannschreck A; von Angerer E; Wiegrebe W Anticancer Drug Des; 1994 Feb; 9(1):25-40. PubMed ID: 8141964 [TBL] [Abstract][Full Text] [Related]
14. Antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,1,2,2-tetraalkyl-1,2 -diphenylethanes. Hartmann RW; Kranzfelder G; von Angerer E; Schönenberger H J Med Chem; 1980 Aug; 23(8):841-8. PubMed ID: 7401112 [TBL] [Abstract][Full Text] [Related]
15. Dibenzo[a,g]quinolizin-8-ones: synthesis, estrogen receptor affinities, and cytostatic activity. von Angerer S; Brandl G; Mannschreck A; Weimar C; Wiegrebe W Anticancer Drug Des; 1992 Oct; 7(5):351-63. PubMed ID: 1388628 [TBL] [Abstract][Full Text] [Related]
16. 2-Alkyl-substituted 1,1-bis(4-acetoxyphenyl)-2-phenylethenes. Estrogen receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activity. Schneider MR J Med Chem; 1986 Aug; 29(8):1494-8. PubMed ID: 3735317 [TBL] [Abstract][Full Text] [Related]
17. Effect of N,N'-diethyl-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines on the 7,12-dimethylbenz[a]anthracene-induced mammary carcinoma of the rat. von Angerer E J Med Chem; 1982 Nov; 25(11):1374-7. PubMed ID: 6815325 [TBL] [Abstract][Full Text] [Related]
18. The inhibitory effect of 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole (D 16726) on estrogen-dependent mammary tumors. von Angerer E; Prekajac J; Berger M Eur J Cancer Clin Oncol; 1985 Apr; 21(4):531-7. PubMed ID: 3924626 [TBL] [Abstract][Full Text] [Related]
19. Affinity of phytoestrogens for estradiol-binding proteins and effect of coumestrol on growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. Verdeal K; Brown RR; Richardson T; Ryan DS J Natl Cancer Inst; 1980 Feb; 64(2):285-90. PubMed ID: 6766510 [TBL] [Abstract][Full Text] [Related]
20. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships. Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]